Member Log-in

I forgot my password

Not a Member? Register

Resources

Our resource library is a searchable collection of tools and documents related to various technical areas around the Gavi transition. The library consists of research articles, policy briefs, reports, guidebooks, country data, and other resources pertinent to Gavi transition or immunization programs generally. You can filter the resources by topic, type, or country. 

Some resources are available to LNCT members only and will require logging in to view. 

Results 1 -10 of 11

Sustaining Pneumococcal Vaccination After Transitioning from Gavi Support: A Modelling and Cost-effectiveness Study in Kenya

Background In 2009, Gavi, the World Bank, and donors launched the pneumococcal Advance Market Commitment, which helped countries access more affordable pneumococcal vaccines. As many low-income countries begin to reach the threshold at which countries transition from Gavi support to self-financing (3-year average gross national income per capita of US$1580), they will need to consider … Continued

Training Video: Applied Health Economics in Africa – Using Examples from Immunization

Using examples from immunizations, this Teaching Vaccine Economics Everywhere (TVEE) training video focuses on developing skills in economic evaluations, carrying out a cost effectiveness and budget impact analysis, and building local capacity in vaccine economics. The training was conducted at a 2019 AfHEA pre-congress session. View the TVEE training video in full.

Expenditures on Vaccine-preventable Disease Surveillance: Analysis and Evaluation of Comprehensive Multi-year Plans (cMYPs) for Immunization

Despite the importance of vaccine-preventable disease (VPD) surveillance, little is known about the costs of monitoring disease. Researchers used Comprehensive Multi-Year Plans for Immunization (cMYPs) – developed by countries following guidelines from the World Health Organization and United Nations Children’s Fund – to estimate expenditures on VPD surveillance at the country level in 2015 US … Continued

Poverty Reduction and Equity Benefits of Introducing or Scaling up Measles, Rotavirus and Pneumococcal Vaccines in Low-income and Middle-income Countries: A Modelling Study

Beyond their impact on health, vaccines can lead to large economic benefits. While most economic evaluations of vaccines have focused on the health impact of vaccines at a national scale, it is critical to understand how their impact is distributed along population subgroups. The team of researchers built a financial risk protection model to evaluate … Continued

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries

A team of researchers modeled the equity impact of lives saved and medical impoverishment averted from immunization over the period 2016-30 in 41 low and middle income countries (DHS survey availability determined which countries were selected for inclusion). Of our 15 LNCT member countries, data from Armenia, Ghana, Indonesia, Nigeria, and Timor-Leste were included in … Continued

ImmunizationEconomics.org – Resource for Immunization Financing, Value, and Costing

ImmunizationEconomics.org is a resource for organizations and individuals involved in the field of immunization economics. The site was originally created in 2015 as part of the EPIC project with funding from the Bill & Melinda Gates Foundation and has key collaborators from the Harvard T.H. Chan School of Public Health, Johns Hopkins University, ThinkWell, and … Continued

Immunization Costing and Financing: A Tool and User Guide for Comprehensive Multi-Year Plan (cMYP) – Update 2014

World Health Organization developed the cMYP Costing and Financing tool to complement the WHO-UNICEF comprehensive Multi-Year Plan guidelines (cMYP). The tool is intended to support strategic planning for immunization program costing and financing and makes it easy to estimate past costs and financing for immunization, to aid in making future projections of resources requirements and financing, … Continued

Return on Investment from Childhood Immunization in Low- and Middle-income Countries, 2011-20

An analysis of return on investment can help policy makers support, optimize, and advocate for the expansion of immunization programs in the world’s poorest countries. We assessed the return on investment associated with achieving projected coverage levels for vaccinations to prevent diseases related to ten antigens in ninety-four low- and middle-income countries during 2011–20, the … Continued

Costs and Financing of Routine Immunization: Approach and Selected Findings of a Multi-country Study (EPIC)

This study provides a wealth of high quality information on total and unit costs and financing for routine immunization, and demonstrates the value of in-depth facility approaches. The paper discusses the lessons learned from using a standardized approach, as well as proposes further areas of methodology development. The paper discusses how results can be used for resource mobilization and allocation, improved efficiency of services at the country level, and to inform policies at the global level.

Estimated Economic Impact of Vaccinations in 73 Low- and Middle-income Countries, 2001-2020

Objective: To estimate the economic impact likely to be achieved by efforts to vaccinate against 10 vaccine-preventable diseases between 2001 and 2020 in 73 low- and middle-income countries largely supported by Gavi, the Vaccine Alliance. Methods: We used health impact models to estimate the economic impact of achieving forecasted coverages for vaccination against Haemophilus influenzae type b, … Continued

Download
File size: 560.21K

Choose a Language